the reversible biochemical changes resulting from the exposure of cultured human synovial cells to gst are discussed as a mechanism of action of this drug on the proliferative synovitis that characterizes diseases such as rheumatoid arthritis .
C0018034
gst
C0003873
rheumatoid arthritis